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The Pseudomonas syringae type III protein secretion sys-
tem (T3SS) and the type III effectors it injects into plant 
cells are required for plant pathogenicity and the ability to 
elicit a hypersensitive response (HR). The HR is a pro-
grammed cell death that is associated with effector-trig-
gered immunity (ETI). A primary function of P. syringae 
type III effectors appears to be the suppression of ETI and 
pathogen-associated molecular pattern–triggered immunity 
(PTI), which is induced by conserved molecules on micro-
organisms. We reported that seven type III effectors from 
P. syringae pv. tomato DC3000 were capable of suppressing 
an HR induced by P. fluorescens(pHIR11) and have now 
tested 35 DC3000 type III effectors in this assay, finding 
that the majority of them can suppress the HR induced by 
HopA1. One newly identified type III effector with particu-
larly strong HR suppression activity was HopS2. We used 
the pHIR11 derivative pLN1965, which lacks hopA1, in 
related assays and found that a subset of the type III effec-
tors that suppressed HopA1-induced ETI also suppressed 
an ETI response induced by AvrRpm1 in Arabidopsis 
thaliana. A. thaliana plants expressing either HopAO1 or 
HopF2, two type III effectors that suppressed the HopA1-
induced HR, were reduced in the flagellin-induced PTI re-
sponse as well as PTI induced by other PAMPs and allowed 
enhanced in planta growth of P. syringae. Collectively, our 
results suggest that the majority of DC3000 type III effec-
tors can suppress plant immunity. Additionally, the con-
struct pLN1965 will likely be a useful tool in determining 
whether other type III effectors or effectors from other 
types of pathogens can suppress either ETI, PTI, or both. 
Pseudomonas syringae is a gram-negative bacterial plant 
pathogen that requires a type III protein secretion system 
(T3SS) and the type III effectors that it injects into plant cells 
to be pathogenic. The T3SS in P. syringae is encoded by hy-
persensitive response and pathogenicity (hrp) and hrp con-
served (hrc) genes in the Hrp pathogenicity island (Alfano et 
al. 2000; Collmer et al. 2000). The T3SS injects type III effec-
tors into host cells in which they contribute to disease in sus-
ceptible plants, primarily by suppression of plant innate immu-
nity (Abramovitch et al. 2006; Espinosa and Alfano 2004). In 
resistant plants however, type III effectors can be recognized 
by plant resistance (R) proteins inducing effector-triggered 
immunity (ETI), which includes the elicitation of the hyper-
sensitive response (HR), a programmed cell death in plants. 
ETI makes up one of the two branches of the innate immune 
system of plants (Jones and Dangl 2006). 
The other branch of the plant innate immune system is acti-
vated by recognition of pathogen-associated molecular patterns 
(PAMPs) and is referred to as PAMP-triggered immunity (PTI) 
(Nurnberger et al. 2004; Zipfel 2008). PAMPs are present in 
pathogenic and nonpathogenic microorganisms and are also 
referred to as microbe-associated molecular patterns (MAMPs) 
(Ausubel 2005). One of the PAMPs whose role in inducing PTI 
is best understood is bacterial flagellin, which is recognized by 
the Arabidopsis thaliana receptor kinase FLS2 (Gomez-Gomez 
and Boller 2000; Zipfel et al. 2004). FLS2 also recognizes a 
conserved peptide of flagellin, flg22, that is often used in assays 
to induce outputs of PTI, including callose (β-1,3 glucan) depo-
sition in the plant cell wall (Gomez-Gomez et al. 1999). 
In 1988, a paper reported a cosmid named pHIR11 that con-
tained a cluster of hrp/hrc genes from P. syringae pv. syringae 
61 that, when expressed in saprophytes such as P. fluorescens, 
conferred upon them the ability to elicit an HR in tobacco 
(Huang et al. 1988). This predated the discovery that hrp/hrc 
genes encoded a T3SS, but it proved to be a useful tool to ex-
plore the function of these genes in P. syringae. For example, 
pHIR11 was instrumental in identifying the first protein found 
to be secreted by the P. syringae T3SS (HrpZ1) (He et al. 
1993). At that time, HrpZ1 was thought to be responsible for 
the HR elicited by P. syringae because it was encoded by 
pHIR11, it was a type III–secreted protein, and purified HrpZ1 
infiltrated into tobacco leaves elicited an HR. However, it was 
subsequently determined that a nonpolar insertion in hrpZ1 in 
pHIR11 retained the ability to elicit an HR when expressed in 
P. fluorescens (Alfano et al. 1996). Thus, even though purified 
HrpZ1 elicited an HR, it was unlikely to be the elicitor of the 
bacterial-induced HR. This realization led to the discovery that 
HopA1 (formerly HrmA and HopPsyA) was the type III 
effector encoded by pHIR11 that was responsible for the 
pHIR11-induced HR and that HopA1 needed to be inside plant 
cells to elicit the HR (Alfano et al. 1997). 
We have used pHIR11 as a tool to elucidate different com-
ponents of the T3SS. For example, we used pHIR11 to help 
show that HopA1 required the ShcA type III chaperone to be 
secreted via the T3SS (van Dijk et al. 2002). Importantly, for 
the research we describe here, we previously used P. fluores-
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cens(pHIR11) in an assay in which we also expressed newly 
discovered type III effectors from P. syringae pv. tomato 
DC3000, to determine whether they could suppress the 
pHIR11-dependent HR. Remarkably, we found that seven of 
the 19 DC3000 type III effectors tested could fully or partially 
suppress the pHIR11-dependent HR (Jamir et al. 2004). 
pHIR11 has also been used to show that Xanthomonas cam-
pestris pv. vesicatoria type III effectors could also suppress 
HopA1-induced ETI (Fujikawa et al. 2006). Thus, pHIR11 has 
proved to be a simple and effective tool to increase our under-
standing of the T3SS in bacterial plant pathogens. 
We modified pHIR11 by substituting hopA1 with a kanamy-
cin-resistance cassette, resulting in construct pLN18 (Jamir et 
al. 2004). This construct allowed us to perform bacterial mix-
ing experiments to show that a type III effector could suppress 
ETI, even when delivered by a different bacterial strain from 
the one injecting the recognized type III effector (Jamir et al. 
2004). Because P. fluorescens(pLN18) does not inject any type 
III effector but does contain PAMPs and induces PTI, this 
strain was used to show that a number of DC3000 type III 
effectors could suppress a PTI output (Oh and Collmer 2005). 
Here, we test 35 DC3000 type III effectors for their ability 
to suppress pHIR11-dependent ETI and find that the majority 
are capable of ETI suppression. We also show that the well-
characterized type III effectors AvrRpm1 and AvrRpt2 are also 
capable of suppressing pHIR11-dependent ETI. We made a de-
rivative of pHIR11 named pLN1965 that substituted hopA1 
with a spectinomycin-resistance cassette. P. fluorescens 
(pLN1965) separately expressing different DC3000 type III 
effectors also suppressed the AvrRpm1-dependent ETI as well 
as PTI in Arabidopsis thaliana. Taken together, our data indi-
cate that the vast majority of the DC3000 type III effectors can 
suppress ETI and that many of them can also suppress PTI. 
This suggests that either common targets for type III effectors 
are utilized in pathways needed for both ETI and PTI, that 
many type III effectors have multiple activities, or both. Addi-
tionally, construct pLN1965 will likely be useful for testing 
whether other type III effectors and effectors from other types 
of plant pathogens can suppress plant immunity. 
RESULTS 
Screening the DC3000 type III effector inventory  
for suppressors of the HopA1 effector-triggered HR.  
The cosmid pHIR11 encodes a functional T3SS and one 
type III effector HopA1 (Alfano and Collmer 1997; Lindeberg 
et al. 2005; van Dijk et al. 1999). We previously used this cos-
mid to screen DC3000 type III effectors for their ability to 
suppress the HopA1-induced HR when expressed in P. fluores-
cens (Jamir et al. 2004). Nineteen type III effectors were 
screened, and five, AvrPtoB (HopAB2), HopE1, HopF2, HopX1 
(AvrPphE), and HopAM1 (AvrPpiB1), were capable of com-
pletely suppressing the HopA1-induced HR, while two others, 
HopD1 and HopK1, had an intermediate ability to suppress 
this HR (Jamir et al. 2004). 
If the DC3000 type III effector inventory is limited to type 
III effectors that have been confirmed or to those for which 
there exists experimental evidence supporting that they are 
type III effectors, there are 36 type III effectors present in 
DC3000 (Lindeberg et al. 2005, 2006). We tested the remain-
ing 29 DC3000 type III effectors in the P. fluorescens(pHIR11) 
assay with the exception of HopI1, due to difficulties in the 
isolation of its gene. Type III effector genes were cloned into 
pLN615 and were transformed into P. fluorescens(pHIR11). 
Each strain expressing individual type III effectors was infil-
trated into tobacco leaves at a cell density of 1 × 108 cells/ml 
and was examined for its ability to suppress the HopA1-depend-
ent HR by comparing each test strain with a control strain on 
the same leaf. Surprising, only one additional type III effector, 
HopS2, was capable of completely suppressing the HopA1-
dependent HR at this cell density (Fig. 1). The suppression 
activity of HopS2 required the presence of the HopS2 cognate 
type III chaperone, which has been shown to be required for 
HopS2 to be secreted via the T3SS (Guo et al. 2005). 
Based on the number of type III effectors that possessed 
suppressor activity in our earlier study (Jamir et al. 2004), we 
expected that many more of the remaining DC3000 type III 
effectors would be capable of suppressing the HopA1-depend-
ent HR. We speculated that our assays may have failed to de-
tect additional DC3000 type III effectors capable of suppress-
ing the HR because the cell densities used far exceeded the 
threshold cell density needed for HR elicitation and this may 
have left unidentified type III effectors that possessed less-sub-
stantial suppressor activity. P. fluorescens(pHIR11) maintains 
its ability to elicit a consistent confluent HR at a cell density of 
2 × 107 cells/ml and, therefore, we retested all of the type III 
effectors at this cell density. When DC3000 type III effectors 
were retested in the P. fluorescens(pHIR11) system at the 
lower cell density, the vast majority of them were able to sup-
press the HopA1-dependent HR (Table 1). To distinguish be-
tween the different levels of HR suppression activity displayed 
Table 1. DC3000 type III effectors tested for their ability to suppress a 
HopA1-dependent hypersensitive response (HR) in tobacco elicited by 
Pseudomonas fluorescens(pHIR11) 
Type III effectors Plasmid Suppression classa 
AvrE pLN2423 II 
AvrPto pLN1327 II 
AvrPtoB pLN347 I 
HopA1 pLN1326 II 
HopB1 pLN271 IV 
HopC1 pLN50 III 
HopD1 pLN167 I 
HopE1 pLN162 I 
HopF2 pLN1420 I 
HopG1 pLN460 II 
HopH1 pLN150 II 
HopI1   Not tested 
HopK1 pCPP5100 I 
HopM1 pLN1156 II 
HopN1 pLN1324 II  
HopO1-1 pLN1622 II 
HopO1-2 pLN1623 II 
HopQ1-1 pLN518 III 
HopR1 pLN1154 II 
HopS2 pLN1624 I 
HopT1-1 pLN256 III 
HopT1-2 pLN567 III 
HopU1 pLN223 II 
HopV1 pLN517 II 
HopX1 pCPP5068 I 
HopY1 pLN1528 II 
HopAA1-1 pLN1326 III 
HopAA1-2 pLN1419 II 
HopAD1 pLN165 III 
HopAF1 pLN164 II 
HopAI1 pLN1011 IV 
HopAM1 pCPP5063 I 
HopAN1 pLN1329 II 
HopAO1 pLN130 II 
HopAQ1 pLN1331 II 
HopAS1′ pLN1328 IV 
a  Class I suppressors are type III effectors that suppressed the HopA1-
dependent HR at 1 × 108 cells/ml; class II completely suppressed the HR
at 2 × 107 cells/ml; class III suppressors are type III effectors that were 
variable in their ability to suppress the HopA1-dependent HR at 2 × 107
cells/ml; and class IV contains type III effectors that were unable to sup-
press the HR at 2 × 107 cells/ml. 
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by different type III effectors, we separated them into different 
suppressor classes: Class I suppressors were type III effectors 
that suppressed the HopA1-dependent HR at 1 × 108 cells/ml, 
class II completely suppressed the HR at 2 × 107 cells/ml, 
class III contained type III effectors that were variable in their 
ability to suppress the HopA1-dependent HR at 2 × 107 cells/ml, 
and class IV contained type III effectors that were unable to 
suppress the HR at 2 × 107 cells/ml. Class I contained eight 
type III effectors, class II contained 18 type III effectors, class 
III contained six type III effectors, and class IV contained 
three type III effectors. 
Two well-studied type III effectors, AvrRpm1 and AvrRpt2, 
can also suppress the HR induced by HopA1.  
Much is known about the activities and targets for the type 
III effectors AvrRpm1 and AvrRpt2 (Axtell and Staskawicz. 
2003; Kim et al. 2005; Mackey et al. 2002, 2003). We tested 
whether these type III effectors were capable of suppressing 
the HR elicited by P. fluorescens(pHIR11) in experiments simi-
lar to the ones described above. The control strain elicited an 
HR at densities of 1 × 108 and 2 × 107 cells/ml, whereas strains 
harboring pVSP61::avrRpm1 and pLN1906, which expressed 
AvrRpm1 and AvrRpt2, respectively, did not elicit an HR at 
these cell densities (Fig. 2). Thus, both AvrRpm1 and AvrRpt2 
strongly suppressed the HopA1-dependent HR in tobacco and, 
by the classification used in Table 1, would both be considered 
class I suppressors. AvrRpm1 and AvrRpt2 have been reported 
to suppress PTI (Kim et al. 2005). Our results indicate that 
AvrRpm1 and AvrRpt2 can also suppress a HopA1-dependent 
ETI response, consistent with earlier reports indicating that 
these type III effectors could interfere with AvrRpm1-dependent 
and AvrRpt2-dependent ETI responses (Reuber and Ausubel 
1996; Ritter and Dangl 1996). 
Testing type III effector suppression of other ETI responses  
using a modified pHIR11 system.  
In our earlier report, we modified pHIR11 by replacing 
hopA1 with a kanamycin-resistance cassette resulting in 
pLN18, which encodes a functional T3SS and allows for the 
injection of other effectors into plant cells when expressed in 
P. fluorescens. However, P. fluorescens(pLN18) is limited be-
cause it uses kanamycin resistance to maintain pLN18. This is 
significant because P. fluorescens 55 is resistant to most of the 
other antibiotics commonly used to select for broad-host-range 
plasmids. To address this issue, we made a derivative of 
pLN18 in which the kanamycin-resistance cassette is replaced 
with a spectinomycin-resistance cassette resulting in construct 
pLN1965. P. fluorescens(pLN1965) allowed us to test whether 
other ETI responses were also suppressed by the type III effec-
tor that suppressed the HopA1-dependent HR. We introduced 
 
Fig. 1. The Pseudomonas syringae pv. tomato DC3000 type III effector HopS2 can suppress the HopA1-dependent hypersensitive response (HR) elicited by
P. fluorescens(pHIR11). P. fluorescens(pHIR11) strains carrying a control vector, pLN1624 (pshcS2 + hopS2) containing hopS2 with its type III chaperone 
gene shcS2, or pLN452 (phopS2) expressing hopS2 alone were infiltrated into Nicotiana tabacum cv. Xanthi leaves at a cell density of 1 × 108 or 2 × 107
cells/ml. The leaves were evaluated for production of a HR and were photographed after 48 h. The ability of HopS2 to suppress the HopA1-dependent HR 
was dependent on the presence of its cognate type III chaperone ShcS2. This experiment was repeated 10 times with similar results. 
 
Fig. 2. Pseudomonas syringae type III effectors AvrRpm1 and AvrRpt2 can suppress the HopA1-dependent hypersensitive response (HR) in tobacco. P. 
fluorescens(pHIR11) strains carrying constructs pVSP61::avrRpm1 (pavrRpm1), pLN1906 (pavrRpt2), or a vector control were infiltrated into Nicotiana 
tabacum cv. Xanthi leaves. P. fluorescens(pHIR11) carrying a vector control elicits a HR at the rate of 1 × 108 and 2 × 107 cells/ml, whereas the HR is 
suppressed in the P. fluorescens(pHIR11) strains expressing avrRpm1 or avrRpt2, indicating that AvrRpm1 and AvrRpt2 can suppress the HopA1-dependent 
HR. Tobacco leaves were evaluated for the development of the HR and were photographed 48 h after infiltration. 
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avrRpm1 on a broad-host-range plasmid into P. fluorescens 
(pLN1965), also carrying compatible plasmids that encoded 
either HopE1, HopF2, AvrPtoB, HopAM1, or HopX1 and infil-
trated each of these strains into A. thaliana Col-0. AvrRpm1 is 
recognized by R protein RPM1 present in this accession of A. 
thaliana, inducing ETI (Grant et al. 1995). All of these type III 
effectors were capable of suppressing the AvrRpm1-dependent 
HR (Fig. 3A). Callose deposition in the plant cell wall is another 
output of ETI. Using the same strains, we determined that each 
of these type III effectors was capable of reducing the amount 
of AvrRpm1-dependent callose deposition (Fig. 3B and C), 
indicating that these type III effectors can suppress multiple 
outputs of ETI. 
Class I HR suppressors can also inhibit  
callose deposition induced by P. fluorescens PAMPs.  
P. fluorescens(pLN1965) does not elicit an HR because it 
does not inject any type III effectors. However, it does contain 
flagellin and likely other PAMPs that are recognized by plants 
that lead to PTI. We found that when P. fluorescens(pLN1965) 
was infiltrated into A. thaliana Col-0 leaves, it induces callose 
deposition (Fig. 4), which is likely due to the recognition of P. 
fluorescens PAMPs. We infiltrated P. fluorescens(pLN1965) 
expressing either AvrPtoB, HopE1, HopF2, HopX1, or 
HopAM1 into A. thaliana Col-0 leaves, to test whether they 
were able to suppress callose deposition induced by P. fluores-
cens(pLN1965). Indeed, in each case, the callose deposition 
was reduced compared with that in a control strain (Fig. 4). 
Taken together, the ability of type III effectors to suppress cal-
lose deposition induced by both AvrRpm1 and P. fluorescens 
(pLN1965) suggests that either ETI and PTI responses overlap 
in their signaling pathways or that type III effectors can 
separately target unique components in each pathway, or both. 
HopAO1 and HopF2 suppress flg22-induced  
innate immunity.  
To further study the suppression of innate immunity by type 
III effectors, we chose to make transgenic A. thaliana Col-0 
 
Fig. 3. Modification of the Pseudomonas fluorescens(pHIR11) system shows that a subset of type III effectors that are class I suppressors can also suppress 
the AvrRpm1-dependent effector-triggered immunity. A, Arabidopsis thaliana ecotype Col-0 leaves were infiltrated with P. fluorescens(pLN1965)(pavrRpm1) 
strains carrying an empty vector (pBBR1MCS5) or constructs that expressed different type III effectors known to suppress the HopA1-dependent hypersensi-
tive response (HR). In each case, the type III effector was also capable of suppressing the AvrRpm1-dependent HR. B, A. thaliana ecotype Col-0 leaves were 
infiltrated with P. fluorescens(pLN1965)(pavrRpm1) strains carrying an empty vector (pBBR1MCS5) or constructs that expressed different type III effectors
known to suppress the HopA1-dependent HR. Callose deposition induced by AvrRpm1 was suppressed in strains that expressed a type III effector known to 
suppress the HopA1-dependent HR. Leaves were microscopically viewed for evidence of callose deposition 16 h after infiltration.C, Callose deposits shown 
in B were quantified, and the average of 20 views of fields from five leaves and standard errors are shown.  
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plants that express either the class I suppressor HopF2 or the 
class II suppressor HopAO1. We have previously shown that 
HopAO1 (formally HopPtoD2) and HopF2 were capable of 
suppressing an HR response induced by an avirulent P. syrin-
gae strain or HopA1 (Espinosa et al. 2003; Jamir et al. 2004). 
We made several independent transgenic A. thaliana Col-0 lines 
that express HopAO1 or HopF2 fused to the hemagglutinin 
(HA) epitope under control of the constitutive Cauliflower 
mosaic virus 35S promoter. We confirmed that these lines ex-
pressed HopAO1-HA or HopF2-HA (Fig. 5A). When a con-
served 22–amino acid peptide (flg22) from flagellin is infil-
trated into A. thaliana, it induces PTI responses, which include 
callose deposition, alkalization, and an oxidative burst in a 
manner dependent on the FLS2 receptor kinase (Felix et al. 
1999; Gomez-Gomez and Boller 2000; Gomez-Gomez et al. 
1999). When 1 μM flg22 was infiltrated into transgenic plants 
expressing HopAO1-HA or HopF2-HA, they showed signifi-
cantly reduced callose deposition compared with wild-type A. 
thaliana Col-0 plants (Fig. 5A and B). An inactive flg22At pep-
tide derived from Agrobacterium flagellin was used as a con-
trol in these experiments, since this peptide is known not to 
induce high levels of callose deposition. Thus, both HopAO1 
and HopF2 exhibited the ability to suppress flg22-induced cal-
lose deposition in A. thaliana. 
Another way to test whether plants expressing HopAO1-HA 
and HopF2-HA were capable of suppressing PTI-dependent cal-
lose deposition is to infiltrate a P. syringae type III–defective 
mutant (Hauck et al. 2003). Since a type III–defective mutant is 
unable to inject any type III effectors, any PAMP recognized by 
the plant results in PTI. We infiltrated a P. syringae pv. tomato 
DC3000 hrcC mutant defective in type III secretion into trans-
genic plants expressing HopAO1-HA or HopF2-HA and exam-
ined callose deposition 16 h postinfiltration. The numbers of cal-
lose deposits were significantly reduced in the HopAO1-HA or 
HopF2-HA transgenic plants compared with wild-type plants 
(Fig. 5C). This result suggests that HopAO1 and HopF2 can 
suppress PAMP-induced callose deposition and is consistent 
with their ability to suppress flg22-induced PTI. 
We determined how much of the callose deposition induced 
by the DC3000 hrcC mutant was due to recognition of flagel-
lin by constructing a DC3000 hrcC fliR double mutant. The 
fliR gene encodes a protein in the flagellar basal body that is 
required for flagellar biogenesis (Fan et al. 1997; Kubori et al. 
1997). We infiltrated the DC3000 hrcC fliR double mutant into 
wild-type A. thaliana and found that it induced less than half 
the number of callose foci than did the DC3000 hrcC single 
mutant (Fig. 5C), suggesting that flagellin is a major PAMP in 
P. syringae–plant interactions. We also infiltrated the DC3000 
hrcC fliR mutant into A. thaliana Col-0 plants expressing either 
HopF2-HA or HopAO1-HA and found the residual callose 
deposition induced by the hrcC fliR mutant was suppressed in 
these plants (Fig. 5C), indicating that these type III effectors 
can suppress PTI induced by PAMPs other than flagellin. 
DC3000 and a DC3000 type III-defective mutant grows  
to higher levels in A. thaliana plants  
expressing HopAO1-HA or HopF2-HA.  
If plants expressing HopAO1-HA or HopF2-HA have a re-
duced PTI response, we thought they may be less able to de-
fend themselves against P. syringae. To test this, we spray-
inoculated DC3000 or the DC3000 hrcC mutant into wild type 
and A. thaliana plants expressing HopAO1-HA or HopF2-HA 
and determined how well each strain grew in these plants. 
DC3000 grew to higher levels in plants expressing either 
HopAO1-HA or HopF2-HA (Fig. 6A). Pretreatment with flg22 
slightly reduced DC3000 growth in all plant lines when com-
pared with the corresponding untreated plants (Fig. 6B). How-
ever, the expression of HopAO1-HA or HopF2-HA allowed 
increased DC3000 growth with or without flg22 pretreatment, 
suggesting that the PTI response is not completely suppressed 
by DC3000 type III effectors. Additionally, growth of DC3000 
in type III effector–expressing plants pretreated with flg22 was 
reduced compared with untreated type III effector–expressing 
plants, which suggests that the PTI response was not completely 
suppressed by the in planta overexpression of these type III 
effectors. 
 
Fig. 4. Type III effectors belonging to the class I suppressor group can suppress callose deposition induced by pathogen-associated molecular pattern 
(PAMP)–triggered immunity. A, Arabidopsis thaliana ecotype Col-0 leaves were infiltrated with Pseudomonas fluorescens(pLN1965) strains carrying an 
empty vector (pBBR1MCS5) or constructs that expressed different type III effectors known to suppress the HopA1-dependent hypersensitive response. 
These type III effectors can suppress callose deposition triggered by PAMPs presented by P. fluorescens(pLN1965). Leaves were microscopically viewed for 
evidence of callose deposition 16 h after infiltration. B, Callose deposits shown in A were quantified, and the average of 20 views of fields from five leaves is 
shown. Each experiment was repeated three times with similar results, and the standard errors are indicated in the bar graphs. 
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The DC3000 hrcC mutant normally has restricted growth in 
planta, likely due to the induction of PTI and the inability of 
this mutant to suppress it by injecting type III effectors. 
Therefore, in planta growth assays using the hrcC mutant is 
another measure of PTI suppression (Hauck et al. 2003). In 
our experiments, the hrcC mutant accumulated to approxi-
mately 300-fold higher levels in A. thaliana plants expressing 
either HopAO1-HA or HopF2-HA compared with wild-type A. 
thaliana Col-0 plants (Fig. 6C). Taken together, these results 
suggest that both HopAO1 and HopF2 suppress PTI and ETI 
responses and this suppression allows the pathogen to grow 
better in plants. 
DISCUSSION 
In this report, we tested 35 DC3000 type III effectors for 
their ability to suppress the HopA1-dependent HR using P. 
fluorescens carrying cosmid pHIR11, which encodes a 
functional T3SS and one type III effector HopA1. The pHIR11 
system was first used to assay for type III effectors that sup-
press the HR by Jamir and associates (2004). This earlier re-
port tested 19 DC3000 type III effectors and identified seven 
that could suppress the HopA1-dependent HR. Here, we have 
extended this assay to include the complete DC3000 inventory 
of confirmed and likely type III effectors (Lindeberg et al. 
2006), with the only exception being HopI1. 
Based on our earlier results, we were expecting many more 
DC3000 type III effectors to completely suppress the HopA1-
dependent HR when P. fluorescens (pHIR11) was infiltrated 
into tobacco at a cell density of 1 × 108 cells/ml. However, we 
identified only one additional DC3000 type III effector capa-
ble of HR suppression at this titer. This prompted us to infil-
trate plants with bacteria at a cell density closer to the thresh-
old cell density needed for production of a macroscopic HR 
and, when we did so, the majority of the DC3000 type III effec-
tors possessed substantial HR suppression activity (Table 1). 
Each DC3000 type III effector was assigned to one of four 
different classes of HR suppressor, and there were only a few 
cases in which we were unable to detect any suppression of the 
HopA1-dependent HR. 
The newly identified DC3000 type III effector as a class I 
suppressor was HopS2. Other than some similarity in its N-ter-
minal secretion signal with HopS1’, HopS2 has no obvious 
similarity with any proteins in the databases (Guo et al. 2005). 
We showed earlier that hopS2 was expressed in conditions that 
induce expression of the T3SS and that HopS2 is injected into 
plant cells in a manner dependent on its type III chaperone 
ShcS2 (Guo et al. 2005). Based on a limited study, hopS2 ap-
peared to be well distributed in different P. syringae pathovars 
(Guo et al. 2005). The fact that this type III effector possesses 
particularly strong HR suppressor activity makes it an attrac-
tive type III effector to study further, to identify its plant tar-
gets. Our HR suppressor screen also included the well-charac-
terized type III effectors AvrRpm1 and AvrRpt2 from other P. 
syringae strains, which were found also to be class I HR sup-
pressors (Fig. 2). Both of these type III effectors are known to 
target RIN4 (Axtell and Staskawicz 2003; Mackey et al. 2003). 
RIN4 associates with RPM1 and RPS2, the R proteins that rec-
ognize AvrRpm1 and AvrRpt2, respectively, and modification 
of RIN4 appears to lead to induction of ETI. It would be of 
interest to know if the HopA1-dependent ETI response is also 
dependent on RIN4. Whatever the case, because of their simi-
larly strong ability to suppress HopA1-induced ETI, it is possi-
ble that the type III effectors that make-up class I suppressors 
target related innate immunity components. 
We modified cosmid pHIR11 to allow us to test whether a 
subset of the class I HR suppressors could also suppress the 
Fig. 5. Transgenic Arabidopsis thaliana plants expressing the HopAO1 or
HopF2 type III effectors were reduced in pathogen-associated molecular
pattern–triggered callose deposition. A, Callose deposition was visualized
in wild-type A. thaliana Col-0 plants or in plants expressing HopAO1 he-
magglutinin (HA) or HopF2-HA 16 h after treatment with flg22 or flg22At, 
an inactive peptide from Agrobacterium flagellin. Immunoblots were car-
ried out using anti-HA antibody on leaf tissue samples from plants used in
the experiment, to confirm that HopAO1-HA and HopF2-HA were pro-
duced. B, Callose deposition in plants depicted in A was quantified by
counting the number of callose foci per field of view. C, Callose deposi-
tion induced by a DC3000 hrcC mutant (defective in the ype III protein
secretion system) or a DC3000 hrcC fliR (defective in flagellar biogensis)
double mutant was quantified as noted in B. The numbers of callose foci
in B and C are averages of 20 fields of view (four views per leaf samples)
and standard errors are shown. All experiments were repeated three times
with similar results. 
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HR induced by a different type III effector. This pHIR11 de-
rivative, pLN1965, still encodes a functional T3SS but lacks 
hopA1. Using P. fluorescens (pLN1965), we showed that the 
type III effectors HopE1, HopF2, AvrPtoB, HopAM1, and 
HopX1, which were class I suppressors, all were capable of 
suppressing the AvrRpm1-dependent HR and callose deposi-
tion in A. thaliana Col-0 (Fig. 3). Because P. fluores-
cens(pLN1965) does not inject any type III effectors that in-
duce ETI but does induce PTI, this system also allowed us to 
demonstrate that these five type III effectors also suppressed 
PTI-induced callose deposition (Fig. 4). In the majority of 
published reports, P. syringae type III effectors have been 
shown to suppress PTI or ETI, but both types of immunity 
generally are not tested. The most notable exceptions to this 
are the type III effectors AvrPtoB and HopAO1, which have 
been shown to suppress both ETI and PTI (Abramovitch and 
Martin 2005; Bretz et al. 2003; de Torres et al. 2006; Espinosa 
et al. 2003; Rosebrock et al. 2007; Underwood et al. 2007). 
The results from this study suggest that many P. syringae type 
III effectors likely suppress both ETI and PTI, possibly be-
cause type III effectors have multiple plant targets or their 
plant targets have roles in either one or both ETI and PTI. 
We envision that P. fluorescens(pLN1965) will be useful for 
researchers studying other type III effectors. For example, they 
could use this system to screen whether the type III effectors 
they are interested in induce ETI or suppress innate immunity. 
Moreover, the system could be adapted for the identification of 
effectors from other bacterial, oomycete, fungal, or viral patho-
gens. Recently oomycete effector genes were identified by 
fusing candidate effector genes to nucleotide sequences corre-
sponding to the N-terminal type III secretion signal of differ-
ent P. syringae type III effectors (Rentel et al. 2008; Sohn et al. 
2007). Expressing these fusion proteins in P. syringae allowed 
them to be injected into plant cells via the T3SS, facilitating 
the discovery of their in planta effects. However, studying 
these heterologous effectors in the wild-type P. syringae back-
ground may mask some of their effects in plant cells, due to 
the injection of many P. syringae type III effectors. We suggest 
that performing analogous experiments using P. fluorescens 
(pLN1965) may provide clearer plant phenotypes because this 
system does not inject any other type III effectors that could 
potentially mask interesting phenotypes. In addition, because 
this strain does not grow well in plant tissue determining 
whether a test effector contributes to in planta growth may be 
made more clear. 
To investigate two of the type III effectors in planta pheno-
types in more detail, we made transgenic A. thaliana plants 
that constitutively expressed a class I suppressor, HopF2, and a 
class II suppressor, HopAO1. We found that transgenic expres-
sion of both of these type III effectors suppressed flg22-
induced PTI (Fig. 5). HopAO1 is a protein tyrosine phospha-
tase that has been previously shown to suppress a nonhost HR 
and other ETI responses (Bretz et al. 2003; Espinosa et al. 
2003), and more recently, it has been shown to suppress PTI 
responses, using transgenic A. thaliana plants expressing 
HopAO1 (Underwood et al. 2007). Our experiments reported 
here with A. thaliana HopOA1-expressing plants essentially 
confirm that these plants are suppressed in their PTI responses. 
In our experiments, flg22 pretreatment still reduced the ability 
of DC3000 to multiply in HopAO1-expressing plants com-
pared with untreated plants. Thus, HopAO1 did not completely 
suppress the PTI response in these plants, as it did in the ear-
lier study. 
The PTI response in A. thaliana plants expressing HopF2 
was also suppressed based on the suppression of flg22-induced 
callose deposition, and the increased growth of the DC3000 
type III–defective hrcC mutant. Other reports have suggested 
that HopF2 was capable of suppressing both ETI in tobacco 
 
Fig. 6. Transgenic Arabidopsis thaliana plants expressing HopAO1 or HopF2 are more susceptible to Pseudomonas syringae and a type III–defective mutant 
than is wild-type Arabidopsis. A, A. thaliana Col-0 plants were spray-inoculated with P. syringae pv. tomato DC3000. DC3000 was able to grow to higher 
levels in plants expressing HopAO1 or HopF2 than in A. thaliana Col-0. B, A. thaliana Col-0 plants were pretreated with 1 μM flg22, and after 16 h, were
spray-inoculated with DC3000. Overall, the pretreatment with flg22 reduced bacterial growth comp plants ared with non-pretreated plants in A. DC3000 
grew to higher levels on plants expressing HopAO1 and HopF2 than it did on A. thaliana Col-0. C, A. thaliana were spray-inoculated with a DC3000 hrcC. 
The growth of the DC3000 hrcC mutant was enhanced in transgenic plants expressing HopAO1 or HopF2 as compared with wild-type Col-0. In all experi-
ments, plants were inoculated at a cell density of 2 × 108 cells/ml, and bacteria were enumerated at days 0 and 4. 
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and PTI in Nicotiana benthamiana when delivered by bacteria 
(Jamir et al. 2004; Oh and Collmer 2005). Another report indi-
cated that HopF2 and a number of other P. syringae type III 
effectors were capable of suppressing flagellin-induced gene 
expression in A. thaliana protoplasts (Li et al. 2005) consistent 
with HopF2 suppressing PTI. The enzymatic activity of HopF2 
and its plant targets are currently unknown. However, its 
molecular structure has been determined, and one portion of it 
shared limited structural similarity with ADP-ribosyltransfer-
ases, but this activity could not be demonstrated (Singer et al. 
2004). The results described here further establish that HopF2 
can suppress both ETI and PTI. 
A DC3000 hrcC fliR double mutant was capable of inducing 
callose deposition, although it was greatly reduced, indicating 
that flagellin is a primary PAMP in A. thaliana Col-0. Trans-
genic A. thaliana plants expressing HopAO1 or HopF2 were 
suppressed in their callose deposition in response to the DC3000 
hrcC fliR double mutant, indicating that these type III effectors 
suppressed PTI responses induced by PAMPs other than flagel-
lin. This is consistent with the induction of PTI in A. thaliana 
plants defective in FLS2, the receptor kinase that recognizes 
flagellin, which suggests that additional bacterial PAMPs are 
recognized by A. thaliana Col-0 (Zipfel et al. 2004). We now 
know that one of these additional bacterial PAMPs is the transla-
tion elongation factor EF-Tu (Zipfel et al. 2006), but likely other 
bacterial PAMPs and PAMP receptors await discovery. 
Evolutionary models suggest that bacterial pathogens first 
acquired type III effectors that suppressed only PTI (Chisholm 
et al. 2006; Espinosa and Alfano 2004). The rationale behind 
this is that the existence of PTI likely predated ETI and that 
PTI probably was the primary selection for pathogens to ini-
tially acquire a T3SS and a minimal set of type III effectors. 
The most logical place to look for genes encoding type III ef-
fectors that target PTI but not ETI is in the conserved effector 
locus (CEL) within the Hrp pathogenicity island (Alfano et al. 
2000) because these type III effectors genes are conserved in 
all P. syringae strains tested and because acquiring an appara-
tus without type III effector genes would serve little benefit to 
the pathogen. Interestingly, two conserved type III effector 
genes within the CEL are avrE and hopM1 and both are class 
II suppressors in HopA1-induced HR suppression assays, indi-
cating that both were capable of suppressing ETI. These re-
sults suggest that these type III effectors either act on host tar-
gets needed for both PTI and ETI, or they contain multiple 
activities, or both. Moreover, these results imply that the arche-
typal type III effectors may have also had the ability to suppress 
both PTI and ETI, which suggests that HopM1 and AvrE1 
target components used in both ETI and PTI. 
Collectively our results indicate that the lion’s share of P. sy-
ringae type III effectors suppress plant innate immunity. How-
ever, they also illustrate the need for assays that report more 
specifically the responses affected in the host as well as the 
Table 2. Strains and plasmids used in this study 
Strain or plasmid Characteristicsa Reference or source 
E. coli   
DH5α supE44 ΔlacU169(φ80lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1, Nalr Hanahan 1983; Life Technologies, 
Gaithersburg, MD, U.S.A. 
DB3.1 F – gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20 (rB– , mB–) supE44 ara-14 galK2 
lacY1 proA2 rpsL20 (Smr) xyl-5 λ– leu mtl-1 
Invitrogen, Carlsbad, CA, U.S.A. 
C2110 PolATS Nalr Kahn and Hanawalt 1979 
Pseudomonas fluorescens 55 Nalr M. Sasser 
DC3000 Wild type; spontaneous Rif r Cuppels 1986 
DC3000 hrcC  hrcC mutant defective in T3SS, Cmr Yuan and He 1996 
UNL143 DC3000 fliR hrcC double mutant, Cmr Spr  This work 
pBluescript-II KS+ Cloning vector, Apr Stratagene, La Jolla, CA, U.S.A. 
pBBR1MCS5 Broad-host-range vector, Gmr Kovach et al. 1995 
pCPP5040 pML123-hemagglutinin (HA) derivative gateway destination vector, Gmr Cmr  
pCPP5063 pCPP5040 derivative carrying hopAM1, Gmr Jamir et al. 2004 
pCPP5068 pCPP5040 derivative carrying hopX1, Gmr Jamir et al. 2004 
pCPP5100 pCPP5040 derivative carrying hopK1, Gmr Jamir et al. 2004 
pENTR/D-TOPO  Gateway system entry vector, Kmr Invitrogen. Carlsbad, CA, U.S.A. 
pHIR11 Cosmid pLAFR3 derivative carring genomic DNA of P. syringae pv. syringae 61, Tcr Huang et al. 1988 
pML123 Broad-host-range cloning vector, Gmr Kmr Labes et al. 1990 
pRK415 Broad-host-range vector, unstable in absence of selection, Tcr Keen et al. 1988 
pVSP61::avrRpm1 pVSP61 derivative carrying avrRpm1, Kmr Mackey et al. 2002 
pLN50 pML123 derivative carrying hopC1-flag, Gmr Jamir et al. 2004 
pLN130 pML123 derivative carrying hopAO1-ha, Gmr Espinosa et al. 2003 
pLN150 pML123 derivative carrying hopH1-flag, Gmr Jamir et al. 2004 
pLN162 pML123 derivative carrying hopE1- flag, Gmr Jamir et al. 2004 
pLN164 pML123 derivative carrying hopAF1-flag, Gmr Jamir et al. 2004 
pLN165 pML123 derivative carrying hopAD1-flag, Gmr Jamir et al. 2004 
pLN167 pML123 derivative carrying hopD1-flag, Gmr  Jamir et al. 2004 
pLN223 pML123 derivative carrying hopU1-flag, Gmr Petnicki-Ocwieja et al. 2002 
pLN256 pML123 derivative carrying hopT1-1-flag, Gmr Guo et al. 2005 
pLN271 pML123 derivative carrying hopB1-flag, Gmr Jamir et al. 2004 
pLN347 pML123 derivative containing avrPtoB-ha, Gmr Jamir et al. 2004 
pLN452 pLN615 derivative containing hopS2, Gmr Guo et al. 
pLN460 pML123 derivative carrying hopG1-flag, Gmr Jamir et al. 2004 
pLN462 pPZP212 derivative gateway destination binary vector containing 35S promoter and  
a HA tag for C-terminal fusions, Spr 
Jamir et al. 2004 
pLN517 pML123 derivative carrying shcV/hopV1-ha, Gmr Jamir et al. 2004 
pLN518 pML123 derivative carrying hopQ1-1-flag, Gmr This work 
pLN525 pLN462 derivative carrying hopF2, Spr Jamir et al. 2004 
  (continued on following page)
a Nalr, Rif r, Cmr, Spr, Apr, Gmr, Kmr, and Tcr = resistant to nalidixic acid, rifampicin, chloramphenicol, spectinomycin, ampicillin, gentamycin, kanamycin,
and tetracycline. 
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urgency to identify specific plant targets and sites of action for 
type III effectors. We are pursuing a line of experimentation to 
do this for several of the type III effectors demonstrated to 
suppress plant immunity. The identification of plant targets for 
type III effectors promises to reveal key strategies for bacterial 
pathogenesis and important undiscovered components of in-
nate immunity. 
MATERIALS AND METHODS 
Bacterial strains, plasmids, and growth conditions.  
The bacterial strains and DNA constructs are listed in Table 
2. E. coli and Agrobacterium strains were grown in Luria-Ber-
tani (LB) medium at 37 and 30°C, respectively, with the ap-
propriate antibiotics. Pseudomonas strains were cultured in 
King’s B (KB) medium at 30°C with antibiotics. The concen-
trations (μg ml–1) of antibiotics used in the experiments are as 
follows: ampicillin, 100; rifampicin, 100; kanamycin, 50; tet-
racycline, 20; spectinomycin, 50; gentamicin, 10; and nalidixic 
acid, 100. 
DNA manipulation.  
Restriction enzymes, T4 DNA ligase, and Taq DNA poly-
merase were purchased from New England Biolabs (Beverly, 
MA, U.S.A.). Thermostable Pfu DNA polymerase (Stratagene, 
La Jolla, CA, U.S.A.) was used to amplify DNA fragments for 
cloning. Primers listed in Table 3 were ordered from Integrated 
DNA Technologies (Coralville, IA, U.S.A.). For Gateway 
cloning, target DNA fragments were amplified by polymerase 
chain reaction (PCR) using Pfu DNA polymerase and were 
cloned into pENTR/D-TOPO (Invitrogen, Carlsbad, CA, 
U.S.A.) following the manufacturer’s instructions. pENTR 
constructs were recombined with Gateway Destination vectors 
by LR reactions using LR Clonase purchased from Invitrogen. 
For construction of pLN1965, which lacks the shcA/hopA1 
operon, a 2.3-kb DNA fragment upstream of shcA was ampli-
fied by PCR from pHIR11, using primers P1892 and P0023, 
and was cloned into the XbaI and EcoRI sites of pBluescript 
KS+, resulting in construct pLN1949. Primers P0227 and 
P0228 were used to PCR-amplify a 1.5-kb DNA region down-
stream of hopA1 from pHIR11, and the amplified product was 
cloned into the XhoI and KpnI sites of pLN1949 resulting in 
construct pLN1952. An omega cassette containing a spectino-
mycin-resistant gene was isolated from pHP45 by digestion 
with EcoRI and was cloned into pLN1952 at the EcoRI site 
within pLN1952, resulting in pLN1954, which was electropo-
rated into E. coli C2110(pHIR11). The resulting strain was 
grown in LB medium containing tetracycline and spectinomy-
cin at 30°C, which was then switched to 37°C for selection of 
recombination events. The pHIR11 derivatives that had under-
gone marker exchange were selected for based on spectinomy-
cin resistance and ampicillin sensitivity and were confirmed 
Table 2. (continued from previous page) 
Strain or plasmid Characteristicsa Reference or source 
pLN567 pML123 derivative carrying hopT1-2-flag, Gmr Guo et al. 2005 
pLN592 pLN462 derivative carrying hopAO1, Spr Espinosa et al. 2003 
pLN615 pML123 derivative gateway destination vector containing a HA tag for C-terminal 
fusions, Gmr Cmr 
This work 
pLN677 pBBR1MCS5 derivatived gateway destination vector containing a HA tag for C-
terminal fusions, Gmr Cmr 
Petnicki-Ocwieja et al. 2005 
pLN682 pLN677 derivative carrying hopE1, Gmr This work 
pLN683 pLN677 derivative carrying shcF/hopF2 operon, Gmr This work 
pLN685 pLN677 derivative carrying avrPtoB, Gmr  This work 
pLN686 pLN677 derivative carrying hopAM1, Gmr This work 
pLN687 pLN677 derivative carrying hopX1, Gmr  This work 
pLN734 pLN1636 derivative containing a 2.0 kb downstream region of fliR. Apr Spr This work 
pLN745 pLN734 derivative containing a 1.5 kb upstream region of fliR. Apr Spr This work 
pLN746 pRK415 derivative containing a 1.5 kb upstream region, a Spr Ω cassette, and a 2.0-kb 
downstream of fliR, Tcr Spr 
This work 
pLN1154 pLN615 derivative carrying hopR1, Gmr This work 
pLN1156 pLN615 derivative carrying shcM/hopM1, Gmr This work 
pLN1323 pLN615 derivative carrying shcA/hopA1 from DC3000, Gmr This work 
pLN1324 pLN615 derivative carrying shcN/hopN1, Gmr This work 
pLN1326 pLN615 derivative carrying hopAA1-1, Gmr This work 
pLN1327 pLN615 derivative carrying avrPto1, Gmr This work 
pLN1328 pLN615 derivative carrying hopAS1′, Gmr This work 
pLN1329 pLN615 derivative carrying hopAN1, Gmr This work 
pLN1331 pLN615 derivative carrying hopAQ1, Gmr This work 
pLN1419 pLN615 derivative carrying hopAA1-2, Gmr  This work 
pLN1420 pLN615 derivative carrying shcF/hopF2, Gmr This work 
pLN1528 pLN615 derivative carrying hopY1, Gmr This work 
pLN1622 pLN615 derivative carrying shcO/hopO1-1, Gmr This work 
pLN1623 pLN615 derivative carrying shcO/hopO1-2, Gmr This work 
pLN1624 pLN615 derivative carrying shcS2/hopS2, Gmr This work 
pLN1636 pBluescript KS- containing Sp resistance Ω cassette at Hind III site. Apr Spr This work 
pLN1906 pDSK509 derivative carrying avrRpt2, Kmr This work 
pLN1949 pBluescript II KS+ derivative carrying a 2.3-kb fragment upstream of shcA in 
pHIR11, Apr 
 
pLN1952 pBluescript II KS+ derivative carrying both a 2.3-kb fragment upstream of shcA and 
1.5 kb fragment downstream of hopA1 in pHIR11, Apr 
This work 
pLN1954  pBluescript-II KS+ derivative carrying both a 2.3-kb fragment upstream of shcA, an 
omega Sp resistant gene cassette, and 1.5-kb fragment downstream of hopA1 in 
pHIR11, Apr Spr 
This work 
pLN1965 pHIR11 derivative containing a deletion of shcA/hopA1 operon that is replaced with 
Sp resistant gene cassette, Tcr Spr 
This work 
pLN2423 pLN615 derivative carrying avrE1, Gmr This work 
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using PCR and digestion with restriction enzymes. One of these 
derivatives that lacked shcA/hopA1 and contained the spectino-
mycin omega cassette was designated pLN1965. This construct 
was introduced into P. fluorescens 55 by triparental mating. 
Construction of a DC3000 fliR hrcC double mutant.  
We used homologous recombination to delete the fliR gene 
in the DC3000 hrcC mutant. To do this, a 2.0-kb downstream 
region of fliR was amplified with primers P1070 and P1071 
and was cloned into pLN1636 in the XhoI and KpnI restriction 
enzyme sites resulting in pLN734. A 1.5-kb upstream region of 
fliR was amplified with primers P1080 and P1081 and was 
cloned into pLN734 in the BamHI and EcoRV sites resulting 
in construct pLN745. A fragment containing the fliR flanking 
regions with an Ω fragment between them was cut out using 
XhoI and EcoRV and was cloned into pRK415, resulting in 
construct pLN746. pLN746 was transformed into the DC3000 
hrcC mutant by electroporation. Homologous recombination in 
the fliR region was selected using spectinomycin and screening 
for loss of tetracycline resistance by growing a DC3000 
hrcC(pLN746) culture for 5 days. Each day a new culture was 
inoculated using the fresh overnight culture in KB medium 
containing spectinomycin. The DC3000 fliR hrcC mutant, 
designated UNL142, was confirmed using PCR. 
Protein manipulation and immunoblots.  
Leaf disks of transgenic and wild-type plants were harvested 
with a 0.64-cm2 cork borer and were ground in liquid nitrogen. 
The ground tissues were resuspended with 100 μl of 1.5× so-
dium dodecyl sulfate (SDS) sample buffer, followed by cen-
trifugation for 5 min at 14,000 rpm. The decanted supernatant 
was subjected to SDS–polyacrylamide gel electrophoresis. The 
proteins were transferred to PVDF (polyvinylidene difluoride) 
membranes (Milipore, Billerica, MA, U.S.A.). Anti-HA primary 
antibodies (Roche, Basal, Switzerland) were used to detect HA 
fusion proteins bound on PVDF membranes. Secondary anti-
bodies used in immunoblots were anti–rat immunoglobulin G 
alkaline-phosphatase conjugates (Sigma Chemical Co., St. 
Louis). Proteins on immunoblots were visualized using the 
CDP-Star chemiluminescence detection kit (Tropix, Bedford, 
MA, U.S.A.) followed by autoradiography. 
Transgenic Arabidopsis plants. 
The Agrobacterium binary constructs pLN592 and pLN525, 
which constitutively express hopAO1-ha and hopF2-ha, re-
spectively, were electroporated into Agrobacterium tumefa-
ciens C58C1. The resulting strains were used for Arabidopsis 
floral-dipping transformation. Transgenic lines were selected 
on Murashige-Skoog plates for kanamycin resistance. The ex-
pression of transgenes was detected by immunoblot using anti-
HA antibodies. Transgenic plant lines with high and stable 
expression of HopAO1-HA or HopF2-HA were used in experi-
ments. 
Plant HR assay.  
The DC3000 type III effector genes to be tested in P. fluo-
rescens HR assays were cloned into pENTR/D-TOPO and 
were then recombined with pLN615, a pML123 destination 
vector that expresses C-terminal HA-tagged proteins (Table 2). 
The resulting constructs were electroporated into P. fluorescens 
(pHIR11). Bacterial strains grown on KB plates were resus-
pended at 1 × 108 cells/ml in 5 mM MES (morpholineethane-
Table 3. Primers for plasmid constructs 
Gene name Construct Primers Sequence 
avrE1 pLN1098 P1127 5′-CACCACAGAGAGATTAACAGTGCAGTCACCATC-3′ 
  P1131 5′-CTCTTCAGTTCGAACCCCTCTTTCTTCAAG-3′ 
avrPto1 pLN307 P689 5′-CACCTGTACTAAAGAGGGTATAAGAATGGGA-3′ 
  P690 5′-TTGCCAGTTACGGTACGGGCT-3′ 
shcA/hopA1 pLN1028 P755 5′-CACCGTTGATGAGCAGAACAATGAGCAAC-3′ 
  P758 5′-TTTCGTGTTTCGAAGGGCCGG-3′ 
shcA/hopA1 pLN1965 P0023 5′-ATGAGAATTCGCATCTCCATGCATCTT-3′ 
  P0227 5′-CGGACTCGAGCTCAGGGCGCGAAACTGA-3′ 
  P0228 5′-GTATGGTACCCCGACCTGGCAACCGCAG-3′ 
  P1892 5′-AGTCTCTAGAGGTGCTATCCACGCAGCG-3′ 
shcF/hopF2 pLN536  P680 5′-CACCACCTTAAATTATGAGGATATGAGG-3′ 
  P682 5′-GACCCTTTCGACCGGCACTTT-3′ 
shcM/hopM1 pLN1464 P1108 5′-CACCCTCAGAGGCCTAACAATGACCAACAATGACCAG-3′ 
  P1128 5′-ACGCGGGTCAAGCAAGCCCTC-3′ 
shcN/hopN1 pLN1070 P1110 5′-CACCAATGAGCGGGGAATAACAATGCGGCCTGTCGAGGCA-3′ 
  P1129 5′-TCGCAAGTGAAAGTCTGCTCTGGGCAC-3′ 
hopR1 pLN1133 P1415 5′-CACCAGGAGTTTAATAATAACGATGGTCAAGG -3′ 
  P634 5′-CACGTTATCGAGTTCGCCCCA-3′ 
hopY1 pLN1491 P1713 5′-CACCGCGATAAAGGGAGATGAAACAATGAAC-3′ 
  P1714 5′-CTGGTAGTTGATGCCCGTGGCG-3′ 
hopAA1-1 pLN887 P1230 5′-CACCGAACGAGAGGGAATAACAATGCACATCAAC-3′ 
  P1231 5′-CGACCGCATAGGCCGAAACGG-3′ 
HopAA1-2 pLN888 P1202 5′-CACCGACCGAGATAGAATAACAATGCACATCAACCAATC-3′ 
  P1203 5′-CAAACGCCTGAGCTGAAACGG-3′ 
hopAI1 pLN1011 P1322 5′-CACCCCCATAAACAAAACAATGCTCGC-3′ 
  P1323 5′-GCGAGTCCAGGGCGGTGGCATCAGC-3′ 
hopAN1 pLN1007 P1314 5′-CACCGCGACCGACCTGGCAACAATGCTGGTGC-3′ 
  P1315 5′-GGCTTCTCCCGCCAATTGCTTGAG-3′ 
hopAQ1 pLN1015 P1310 5′-CACCCAAAGAGGTTTAACAATGAATCGAATTTC-3′ 
  P1311 5′-TGCACTGCCACCAGCAATCGAGCG-3′ 
hopAS1 pLN1009 P1318 5′-CACCCGATGGAGCCCAACAATGACCTTAAG-3′ 
  P1319 5′-AGAAAACTCGGCTTTCTGTTCAACC-3′ 
fliR pLN746 P1070 5′-ATGACTCGAGGCTCGTTGAGATGGCAG A-3′ 
  P1071 5′-ATGAGGTACCTGCTGAAAGATACCGACC-3′ 
  P1080 5′-ATGAGGATCCCACATGCGCCCTGGCGATG-3′ 
  P1081 5′-ATGAGATATCGGTACTGATCTGGATATCGGTCAG-3′ 
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sulfonic acid), pH 5.6; three fivefold serial dilutions were 
made, and each dilution was infiltrated into Nicotiana tabacum 
cv. Xanthi leaves side by side with the vector control strain P. 
fluorescens(pHIR11 + pML123). HR responses were recorded 
24 to 48 h after infiltration. 
Callose deposition assay.  
To induce callose deposition wild-type A. thaliana Col-0 or 
transgenic plants were infiltrated with 1 μM flg22 or flg22At (flg22 from Agrobacterium, which is not recognized by FLS2 
in Col-0). Alternatively, they were infiltrated with either the 
hrcC mutant or the hrcC fliR double mutant. In an additional 
strategy, we expressed AvrPtoB (pLN685), HopE1 (pLN682), 
HopF2 (pLN683), HopX1 (pLN687), HopAM1 (pLN686), and 
pBBR1MCS-5 (vector) in P. fluorescens(pLN1965). The sus-
pensions of the strains were infiltrated into Col-0 at 1 × 107 
cells/ml. For the experiments to determine if the type III effec-
tors suppress callose deposition induced by AvrRpm1, pLN685 
(AvrPtoB), pLN682 (HopE1), pLN683 (HopF2), pLN686 
(HopAM1), pLN687 (HopX1), and pBBR1MCS-5 were elec-
troporated into P. fluorescens(pLN1965) harboring 
pVSP61::avrRpm1. The resulting strains were infiltrated into 
A. thaliana Col-0 at a rate of 1 × 106 cells/ml. To determine the 
levels of callose deposition 16 h after infiltration, leaf samples 
were cleared with an alcoholic lactophenol solution, followed 
by a rinse in 50% ethanol and a rinse in water as described 
(Adam and Somerville 1996). The completely cleared leaves 
were stained with 0.01% (wt/vol) aniline blue in a solution of 
150 mM K2HPO4, pH 9.5, for 30 min. The callose deposits 
were visualized with a fluorescence microscope (Zeiss Axion-
plan 2, Carl Zeiss, Oberkochen, Germany), and the number of 
callose deposits was determined using Quantity One software 
(Bio-Rad, Hercules, CA, U.S.A.). 
In planta growth and pathogenicity assays.  
Wild-type A. thaliana Col-0 or transgenic plants were grown 
in a growth chamber at 24°C with 10 h of light per day. Bacte-
rial growth in Col-0 and transgenic plants was determined by 
spray-inoculating A. thaliana leaves with DC3000 or the 
DC3000 type III–defective hrcC mutant. In some instances, 
plants were pretreated with flg22 by infiltration of either 1 μM 
flg22 or 1 μM flg22At. Plants were spray-inoculated with bac-
terial suspensions 12 h after pretreatment. The ability of bacte-
ria to grow in planta was determined as described previously 
(Espinosa et al. 2003). Briefly, four leaf disks were harvested 
with a 0.4-cm2 cork borer 0 and 4 days after inoculation. The 
samples were macerated in 250 μl of sterile water for 1 min 
and were serially diluted. Each dilution (20 μl) was plated on 
KB medium containing the appropriate antibiotics. The colo-
nies recovered after 48 h on plates were enumerated. 
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